P20GM152302

Alaska Native Center for Health Research (ANCHR) - Project Summary/Abstract – Overall the Alaska Native Tribal Health Consortium (ANTHC) vision is that “Alaska Native people are the healthiest people in the world”.
To achieve this vision and to address the many health disparities faced by our Alaska Native (AN) people, ANTHC recognizes the need for research.
Current health research activities at ANTHC build on a 65-year history of research with AN people and encompass a wide spectrum of health issues.

Research has made a dramatic contribution on the lives of the AN people and ANTHC recognizes the importance of maintaining a robust research department with staff who are dedicated to research with AN people and who understand the importance of tribally driven research.
The overall goals of the proposed Alaska Native Center for Health Research (ANCHR) are to develop a cadre of investigators in Alaska engaged in research to address health disparities in the Alaska Native population; expand the capacity for health disparities research in Alaska; and encourage the recruitment of AN investigators into health disparities research careers at ANTHC and other organizations in Alaska.

These goals fully align with the ANTHC vision and mission through partnerships with communities, tribal health organizations (THO), academic institutions, and others to optimize health through addressing AN health disparities.
Hiring of new staff, particularly Alaska Native or American Indian (AN/AI) individuals will expand our capacity to achieve our goal.
We will accomplish these goals through the following specific aims:

Aim 1: Develop a cadre of ANCHR investigators based at ANTHC and other THOs and academic institutions in Alaska engaged in research to address identified AN health disparities, through ensuring robust and sustained mentorship of research project leads (RPLs), recruitment of AN individuals as project leads and support to RPLs in generating preliminary data and in writing research proposals to secure independent funding.

Aim 2: Strengthen capacity to support the RPLs and other investigators through the research core in research design, epidemiology, biostatistics, data management, qualitative research methods, research staff and community engagement and ensuring there is tribal engagement, consultation, and oversight throughout the duration of all projects.

Aim 3: Establish and fund training/educational opportunities to expand the skills of RPLs and other investigators and actively recruit AN people into health research careers, including participation in the NARCH funded Alaska Indigenous Research Program and NIH grant writing training and grant mock reviews.

COBRE funding for research projects and the opportunity to hire and train new investigators, will empower the ANCHR to expand our capacity to conduct research to address health disparities in the AN population.

Alaska Native Tribal Health Consortium

THE NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES (NIGMS) SUPPORTS BASIC RESEARCH THAT INCREASES OUR UNDERSTANDING OF BIOLOGICAL PROCESSES AND LAYS THE FOUNDATION FOR ADVANCES IN DISEASE DIAGNOSIS, TREATMENT, AND PREVENTION. NIGMS ALSO SUPPORTS RESEARCH IN SPECIFIC CLINICAL AREAS THAT AFFECT MULTIPLE ORGAN SYSTEMS: ANESTHESIOLOGY AND PERI-OPERATIVE PAIN, CLINICAL PHARMACOLOGY ?COMMON TO MULTIPLE DRUGS AND TREATMENTS, AND INJURY, CRITICAL ILLNESS, SEPSIS, AND WOUND HEALING.? NIGMS-FUNDED SCIENTISTS INVESTIGATE HOW LIVING SYSTEMS WORK AT A RANGE OF LEVELSFROM MOLECULES AND CELLS TO TISSUES AND ORGANSIN RESEARCH ORGANISMS, HUMANS, AND POPULATIONS. ADDITIONALLY, TO ENSURE THE VITALITY AND CONTINUED PRODUCTIVITY OF THE RESEARCH ENTERPRISE, NIGMS PROVIDES LEADERSHIP IN SUPPORTING THE TRAINING OF THE NEXT GENERATION OF SCIENTISTS, ENHANCING THE DIVERSITY OF THE SCIENTIFIC WORKFORCE, AND DEVELOPING RESEARCH CAPACITY THROUGHOUT THE COUNTRY.

93.859 - Biomedical Research and Research Training

National Institute of General Medical Sciences (NIGMS) [HHS - NIH]

Anchorage, Alaska 99508 United States

Single Zip Code

Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional) (PAR-22-250)

Amendment Since initial award the total obligations have increased 99% from $1,682,495 to $3,355,444.